Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$245,177,551
-$80,700,449 QoQ
Shares Held
1,940,617
-17.0% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#78
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $2,885,207,124 across 10 Drug Manufacturers - General names. GILD ranks #4 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
895,262 | $1,073,804,190 | |
| 2 | JNJ |
Johnson & Johnson
|
2,064,646 | $524,358,144 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,364,831 | $432,380,783 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
1,940,617 | $245,177,551 | |
| 5 | ABBV |
AbbVie Inc.
|
861,436 | $216,771,755 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,865,663 | $165,119,502 | |
| 7 | PFE |
Pfizer Inc
|
5,127,377 | $123,467,238 | |
| 8 | AMGN |
Amgen Inc
|
236,929 | $85,796,729 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,177,551 | 1,940,617 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $325,878,000 | 2,338,222 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $237,669,931 | 1,936,369 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $294,972,732 | 2,657,412 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $254,746,220 | 2,297,702 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $240,349,154 | 2,145,017 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $154,245,984 | 1,669,871 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $134,931,844 | 1,609,397 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $98,032,575 | 1,428,838 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $105,024,238 | 1,433,778 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $241,356,981 | 2,979,348 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $268,187,778 | 3,578,700 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $280,663,969 | 3,641,676 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $296,673,671 | 3,575,674 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $339,999,824 | 3,960,394 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $276,665,399 | 4,484,769 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $166,529,120 | 2,694,210 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $131,085,466 | 2,204,970 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $112,870,938 | 1,554,482 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $138,793,975 | 1,987,029 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $145,942,710 | 2,119,412 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $119,393,131 | 1,847,333 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $91,835,937 | 1,576,312 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $66,766,174 | 1,056,594 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $96,513,074 | 1,254,394 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $112,040,943 | 1,498,675 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||